David Shaw’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.3M Sell
140,324
-265,668
-65% -$98.5M 0.03% 720
2026
Q1
$119M Sell
405,992
-86,004
-17% -$28.3M 0.07% 319
2025
Q4
$172M Sell
491,996
-282,887
-37% -$95.6M 0.09% 236
2025
Q3
$250M Buy
774,883
+125,879
+19% +$39.2M 0.14% 152
2025
Q2
$252M Buy
649,004
+408,730
+170% +$164M 0.18% 112
2025
Q1
$105M Sell
240,274
-465,395
-66% -$187M 0.09% 265
2024
Q4
$260M Buy
705,669
+650,602
+1,181% +$272M 0.19% 105
2024
Q3
$28.6M Sell
55,067
-185,189
-77% -$98.9M 0.02% 789
2024
Q2
$130M Sell
240,256
-76,657
-24% -$40.5M 0.12% 185
2024
Q1
$164M Buy
316,913
+52,344
+20% +$26M 0.14% 147
2023
Q4
$125M Sell
264,569
-61,560
-19% -$28.5M 0.11% 217
2023
Q3
$142M Buy
326,129
+21,371
+7% +$9.69M 0.15% 152
2023
Q2
$135M Buy
304,758
+117,491
+63% +$54.2M 0.14% 164
2023
Q1
$86.1M Sell
187,267
-150,826
-45% -$71.8M 0.09% 258
2022
Q4
$173M Buy
338,093
+105,776
+46% +$53.7M 0.19% 93
2022
Q3
$106M Sell
232,317
-9,884
-4% -$4.73M 0.13% 155
2022
Q2
$117M Buy
242,201
+110,242
+84% +$54.5M 0.14% 145
2022
Q1
$64.8M Buy
131,959
+33,080
+33% +$15.1M 0.06% 382
2021
Q4
$45.8M Sell
98,879
-18,689
-16% -$7.86M 0.04% 601
2021
Q3
$43.8M Buy
117,568
+4,295
+4% +$1.63M 0.04% 589
2021
Q2
$43.2M Buy
113,273
+74,171
+190% +$28.3M 0.04% 621
2021
Q1
$14M Sell
39,102
-101,805
-72% -$32.7M 0.01% 1150
2020
Q4
$45.2M Sell
140,907
-68,082
-33% -$20.9M 0.04% 536
2020
Q3
$56.1M Buy
208,989
+52,451
+34% +$14.1M 0.06% 378
2020
Q2
$41.2M Buy
156,538
+51,600
+49% +$13.8M 0.05% 435
2020
Q1
$23.8M Buy
104,938
+75,827
+260% +$20.7M 0.04% 544
2019
Q4
$8.79M Buy
29,111
+2,534
+10% +$697K 0.01% 1297
2019
Q3
$6.38M Buy
26,577
+24,377
+1,108% +$6.68M 0.01% 1458
2019
Q2
$621K Sell
2,200
-3,795
-63% -$1.04M ﹤0.01% 2967
2019
Q1
$1.72M Sell
5,995
-15,605
-72% -$4.51M ﹤0.01% 2266
2018
Q4
$5.67M Buy
21,600
+20,500
+1,864% +$5.64M 0.01% 1438
2018
Q3
$301K Hold
1,100
﹤0.01% 3360
2018
Q2
$262K Sell
1,100
-1,793
-62% -$415K ﹤0.01% 3434
2018
Q1
$635K Sell
2,893
-30,596
-91% -$7.19M ﹤0.01% 2772
2017
Q4
$7.54M Buy
33,489
+351
+1% +$74.8K 0.01% 1211
2017
Q3
$6.29M Sell
33,138
-608
-2% -$116K 0.01% 1215
2017
Q2
$6.35M Sell
33,746
-18,579
-36% -$3.34M 0.01% 1166
2017
Q1
$8.65M Sell
52,325
-303,487
-85% -$48.3M 0.02% 959
2016
Q4
$51.2M Buy
355,812
+95,342
+37% +$12.8M 0.09% 288
2016
Q3
$32.6M Buy
260,470
+109,914
+73% +$14.2M 0.06% 420
2016
Q2
$19.8M Sell
150,556
-268,947
-64% -$36.8M 0.04% 552
2016
Q1
$58.3M Buy
419,503
+72,450
+21% +$9.68M 0.1% 234
2015
Q4
$48.4M Buy
347,053
+91,908
+36% +$12.7M 0.07% 326
2015
Q3
$35.7M Sell
255,145
-130,164
-34% -$19.6M 0.05% 406
2015
Q2
$63.2M Sell
385,309
-140,614
-27% -$22.5M 0.09% 251
2015
Q1
$81.2M Sell
525,923
-39,874
-7% -$5.68M 0.12% 176
2014
Q4
$71.1M Buy
+565,797
New +$69.9M 0.09% 260
2014
Q3
Sell
-374,758
Closed -$43M 4162
2014
Q2
$40.3M Sell
374,758
-162,633
-30% -$16.8M 0.05% 393
2014
Q1
$53.5M Buy
537,391
+521,258
+3,231% +$47.1M 0.08% 286
2013
Q4
$1.49M Sell
16,133
-6,907
-30% -$614K ﹤0.01% 2803
2013
Q3
$1.93M Buy
+23,040
New +$1.97M ﹤0.01% 2462

Other funds holding ELV

David Shaw's ELV Position: Q2 2026 in Review

David Shaw reduced its Elevance Health (ELV) stake by 65% in Q2 2026, selling an estimated $98.5M and leaving 140,324 shares worth $54.3M. The position accounts for 0.03% of the portfolio, ranked #720.

David Shaw first reported a position in ELV in Q3 2013 and has held it in 51 quarters since. The position peaked at $260M in Q4 2024. 1,596 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • David Shaw held 140,324 shares of Elevance Health worth $54.3M as of Q2 2026.
  • David Shaw sold 265,668 Elevance Health shares in Q2 2026, an estimated $98.5M.
  • Elevance Health made up 0.03% of David Shaw's portfolio in Q2 2026, its #720 holding.
  • David Shaw first reported a position in Elevance Health in Q3 2013 and has held it in 51 quarters since.
  • David Shaw's Elevance Health position peaked at $260M in Q4 2024.
  • 1,596 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.